Retinal Ganglion Cell Functional Recovery after Intraocular Pressure Lowering Treatment Using Prostaglandin Analogs in Glaucoma Suspects: A Prospective Pilot Study

To evaluate the ability of pattern electroretinogram (PERG) to detect improvement of retinal ganglion cell (RGC) function in glaucoma suspects (GS) after medically reducing intraocular pressure (IOP) using prostaglandin analog drops. Six subjects (eight eyes) received topical IOP lowering treatment...

Full description

Saved in:
Bibliographic Details
Published inJournal of current glaucoma practice Vol. 17; no. 4; pp. 178 - 190
Main Authors Sheha, Hosam, Tirsi, Andrew, Gliagias, Vasiliki, Patel, Bhakti, Moehringer, Julie, Tsai, Joby, Gupta, Rohun, Obstbaum, Stephen A, Tello, Celso
Format Journal Article
LanguageEnglish
Published India Jaypee Brothers Medical Publishers 01.10.2023
Subjects
Online AccessGet full text
ISSN0974-0333
0975-1947
DOI10.5005/jp-journals-10078-1423

Cover

Abstract To evaluate the ability of pattern electroretinogram (PERG) to detect improvement of retinal ganglion cell (RGC) function in glaucoma suspects (GS) after medically reducing intraocular pressure (IOP) using prostaglandin analog drops. Six subjects (eight eyes) received topical IOP lowering treatment based on their clinical examination and were observed at Manhattan Eye, Ear & Throat Hospital over an average of 3.1 ± 2.2 months. During this time, participants underwent a full ophthalmologic exam and were evaluated with a Humphrey visual field analyzer (HFA) 24-2 [24-2 mean deviation (MD), 24-2 pattern standard deviation (PSD), and 24-2 visual field indices (VFI)], Diopsys NOVA PERG optimized for glaucoma [magnitude (Mag), magnitudeD (MagD), and magnitudeD/magnitude ratio (MagD/Mag ratio)] and optical coherence tomography (OCT)-derived average retinal nerve fiber layer thickness (avRNFLT) and average ganglion cell layer + inner plexiform layer (avGCL + IPL) thicknesses at baseline visit (pretreatment) and 3 months later (posttreatment). Goldman applanation tonometry was used to measure IOP at each visit. Paired sample -tests were conducted to determine the statistical significance of the change in IOP, HFA indices, PERG parameters, and OCT thickness measurements between the two visits. Lowering IOP by 22.29% resulted in a significant increase (32.98 and 15.49%) in MagD [ (7) = -3.174, 95% confidence interval (CI) = -0.53, -0.08, = 0.016] and MagD/Mag ratio [ (7) = -3.233, 95% CI = -0.20, -0.03, = 0.014], respectively. There was a positive percentage change for all variables of interest, however, 24-2 MD, Mag, avRNFLT, and GCL+ IPLT did not reach statistical significance. After reducing IOP by 22.29% for a duration of 3.1 months, the PERG parameters, MagD and MagD/Mag ratio, significantly improved by 32.98 and 15.49%, respectively. Pattern electroretinogram (PERG) may be a crucial tool for clinicians to locate a window of opportunity in which degenerating yet viable RGCs could be rescued from irreversible damage. We suggest consideration of PERG as a tool in early retinal ganglion cell (RGC) dysfunction detection as well as for monitoring IOP lowering treatment. Tirsi A, Gliagias V, Sheha H, Retinal Ganglion Cell Functional Recovery after Intraocular Pressure Lowering Treatment Using Prostaglandin Analogs in Glaucoma Suspects: A Prospective Pilot Study. J Curr Glaucoma Pract 2023;17(4):178-190.
AbstractList To evaluate the ability of pattern electroretinogram (PERG) to detect improvement of retinal ganglion cell (RGC) function in glaucoma suspects (GS) after medically reducing intraocular pressure (IOP) using prostaglandin analog drops.Aim and backgroundTo evaluate the ability of pattern electroretinogram (PERG) to detect improvement of retinal ganglion cell (RGC) function in glaucoma suspects (GS) after medically reducing intraocular pressure (IOP) using prostaglandin analog drops.Six subjects (eight eyes) received topical IOP lowering treatment based on their clinical examination and were observed at Manhattan Eye, Ear & Throat Hospital over an average of 3.1 ± 2.2 months. During this time, participants underwent a full ophthalmologic exam and were evaluated with a Humphrey visual field analyzer (HFA) 24-2 [24-2 mean deviation (MD), 24-2 pattern standard deviation (PSD), and 24-2 visual field indices (VFI)], Diopsys NOVA PERG optimized for glaucoma [magnitude (Mag), magnitudeD (MagD), and magnitudeD/magnitude ratio (MagD/Mag ratio)] and optical coherence tomography (OCT)-derived average retinal nerve fiber layer thickness (avRNFLT) and average ganglion cell layer + inner plexiform layer (avGCL + IPL) thicknesses at baseline visit (pretreatment) and 3 months later (posttreatment). Goldman applanation tonometry was used to measure IOP at each visit. Paired sample t-tests were conducted to determine the statistical significance of the change in IOP, HFA indices, PERG parameters, and OCT thickness measurements between the two visits.Materials and methodsSix subjects (eight eyes) received topical IOP lowering treatment based on their clinical examination and were observed at Manhattan Eye, Ear & Throat Hospital over an average of 3.1 ± 2.2 months. During this time, participants underwent a full ophthalmologic exam and were evaluated with a Humphrey visual field analyzer (HFA) 24-2 [24-2 mean deviation (MD), 24-2 pattern standard deviation (PSD), and 24-2 visual field indices (VFI)], Diopsys NOVA PERG optimized for glaucoma [magnitude (Mag), magnitudeD (MagD), and magnitudeD/magnitude ratio (MagD/Mag ratio)] and optical coherence tomography (OCT)-derived average retinal nerve fiber layer thickness (avRNFLT) and average ganglion cell layer + inner plexiform layer (avGCL + IPL) thicknesses at baseline visit (pretreatment) and 3 months later (posttreatment). Goldman applanation tonometry was used to measure IOP at each visit. Paired sample t-tests were conducted to determine the statistical significance of the change in IOP, HFA indices, PERG parameters, and OCT thickness measurements between the two visits.Lowering IOP by 22.29% resulted in a significant increase (32.98 and 15.49%) in MagD [t (7) = -3.174, 95% confidence interval (CI) = -0.53, -0.08, p = 0.016] and MagD/Mag ratio [t (7) = -3.233, 95% CI = -0.20, -0.03, p = 0.014], respectively. There was a positive percentage change for all variables of interest, however, 24-2 MD, Mag, avRNFLT, and GCL+ IPLT did not reach statistical significance.ResultsLowering IOP by 22.29% resulted in a significant increase (32.98 and 15.49%) in MagD [t (7) = -3.174, 95% confidence interval (CI) = -0.53, -0.08, p = 0.016] and MagD/Mag ratio [t (7) = -3.233, 95% CI = -0.20, -0.03, p = 0.014], respectively. There was a positive percentage change for all variables of interest, however, 24-2 MD, Mag, avRNFLT, and GCL+ IPLT did not reach statistical significance.After reducing IOP by 22.29% for a duration of 3.1 months, the PERG parameters, MagD and MagD/Mag ratio, significantly improved by 32.98 and 15.49%, respectively.ConclusionAfter reducing IOP by 22.29% for a duration of 3.1 months, the PERG parameters, MagD and MagD/Mag ratio, significantly improved by 32.98 and 15.49%, respectively.Pattern electroretinogram (PERG) may be a crucial tool for clinicians to locate a window of opportunity in which degenerating yet viable RGCs could be rescued from irreversible damage. We suggest consideration of PERG as a tool in early retinal ganglion cell (RGC) dysfunction detection as well as for monitoring IOP lowering treatment.Clinical significancePattern electroretinogram (PERG) may be a crucial tool for clinicians to locate a window of opportunity in which degenerating yet viable RGCs could be rescued from irreversible damage. We suggest consideration of PERG as a tool in early retinal ganglion cell (RGC) dysfunction detection as well as for monitoring IOP lowering treatment.Tirsi A, Gliagias V, Sheha H, et al. Retinal Ganglion Cell Functional Recovery after Intraocular Pressure Lowering Treatment Using Prostaglandin Analogs in Glaucoma Suspects: A Prospective Pilot Study. J Curr Glaucoma Pract 2023;17(4):178-190.How to cite this articleTirsi A, Gliagias V, Sheha H, et al. Retinal Ganglion Cell Functional Recovery after Intraocular Pressure Lowering Treatment Using Prostaglandin Analogs in Glaucoma Suspects: A Prospective Pilot Study. J Curr Glaucoma Pract 2023;17(4):178-190.
To evaluate the ability of pattern electroretinogram (PERG) to detect improvement of retinal ganglion cell (RGC) function in glaucoma suspects (GS) after medically reducing intraocular pressure (IOP) using prostaglandin analog drops. Six subjects (eight eyes) received topical IOP lowering treatment based on their clinical examination and were observed at Manhattan Eye, Ear & Throat Hospital over an average of 3.1 ± 2.2 months. During this time, participants underwent a full ophthalmologic exam and were evaluated with a Humphrey visual field analyzer (HFA) 24-2 [24-2 mean deviation (MD), 24-2 pattern standard deviation (PSD), and 24-2 visual field indices (VFI)], Diopsys NOVA PERG optimized for glaucoma [magnitude (Mag), magnitudeD (MagD), and magnitudeD/magnitude ratio (MagD/Mag ratio)] and optical coherence tomography (OCT)-derived average retinal nerve fiber layer thickness (avRNFLT) and average ganglion cell layer + inner plexiform layer (avGCL + IPL) thicknesses at baseline visit (pretreatment) and 3 months later (posttreatment). Goldman applanation tonometry was used to measure IOP at each visit. Paired sample -tests were conducted to determine the statistical significance of the change in IOP, HFA indices, PERG parameters, and OCT thickness measurements between the two visits. Lowering IOP by 22.29% resulted in a significant increase (32.98 and 15.49%) in MagD [ (7) = -3.174, 95% confidence interval (CI) = -0.53, -0.08, = 0.016] and MagD/Mag ratio [ (7) = -3.233, 95% CI = -0.20, -0.03, = 0.014], respectively. There was a positive percentage change for all variables of interest, however, 24-2 MD, Mag, avRNFLT, and GCL+ IPLT did not reach statistical significance. After reducing IOP by 22.29% for a duration of 3.1 months, the PERG parameters, MagD and MagD/Mag ratio, significantly improved by 32.98 and 15.49%, respectively. Pattern electroretinogram (PERG) may be a crucial tool for clinicians to locate a window of opportunity in which degenerating yet viable RGCs could be rescued from irreversible damage. We suggest consideration of PERG as a tool in early retinal ganglion cell (RGC) dysfunction detection as well as for monitoring IOP lowering treatment. Tirsi A, Gliagias V, Sheha H, Retinal Ganglion Cell Functional Recovery after Intraocular Pressure Lowering Treatment Using Prostaglandin Analogs in Glaucoma Suspects: A Prospective Pilot Study. J Curr Glaucoma Pract 2023;17(4):178-190.
Author Tirsi, Andrew
Moehringer, Julie
Gliagias, Vasiliki
Gupta, Rohun
Obstbaum, Stephen A
Tsai, Joby
Sheha, Hosam
Tello, Celso
Patel, Bhakti
AuthorAffiliation 6 Broward Health Medical Center, Fort Lauderdale, United States
5 Sanford H. Calhoun High School, Merrick, New York, United States
1,3,8,9 Manhattan Eye, Ear and Throat Hospital; Donald and Barbara Zucker School of Medicine at Hofstra University/Northwell Health, Hempstead, New York, United States
2,4,7 Donald and Barbara Zucker School of Medicine at Hofstra University/Northwell Health, Hempstead, New York, United States
AuthorAffiliation_xml – name: 6 Broward Health Medical Center, Fort Lauderdale, United States
– name: 2,4,7 Donald and Barbara Zucker School of Medicine at Hofstra University/Northwell Health, Hempstead, New York, United States
– name: 1,3,8,9 Manhattan Eye, Ear and Throat Hospital; Donald and Barbara Zucker School of Medicine at Hofstra University/Northwell Health, Hempstead, New York, United States
– name: 5 Sanford H. Calhoun High School, Merrick, New York, United States
Author_xml – sequence: 1
  givenname: Hosam
  surname: Sheha
  fullname: Sheha, Hosam
– sequence: 2
  givenname: Andrew
  surname: Tirsi
  fullname: Tirsi, Andrew
– sequence: 3
  givenname: Vasiliki
  surname: Gliagias
  fullname: Gliagias, Vasiliki
– sequence: 4
  givenname: Bhakti
  surname: Patel
  fullname: Patel, Bhakti
– sequence: 5
  givenname: Julie
  surname: Moehringer
  fullname: Moehringer, Julie
– sequence: 6
  givenname: Joby
  surname: Tsai
  fullname: Tsai, Joby
– sequence: 7
  givenname: Rohun
  surname: Gupta
  fullname: Gupta, Rohun
– sequence: 8
  givenname: Stephen A
  surname: Obstbaum
  fullname: Obstbaum, Stephen A
– sequence: 9
  givenname: Celso
  surname: Tello
  fullname: Tello, Celso
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38269268$$D View this record in MEDLINE/PubMed
BookMark eNqFUttq3DAQFSWlSdP8QtBjX9zKli1bpVCWpdkGFrrk8iy00tjVYkuuJG_Y7-mPVt5caPtSgdAMc-aMZua8RSfWWUDoMicfKkKqj7sx27nJW9mHLCekbrK8LOgrdEZ4XWU5L-uTo11mhFJ6ii5C2JF0ynQ5f4NOaVMwXrDmDP26gWgSEV5J2_XGWbyEvsdXk1UxeSlwA8rtwR-wbCN4fG2jl05NvfR44yGEyQNeuwfwxnb4zoOMA9iI78Psb7wLUXa9tNpYvEh8rgs4mateTsoNEt9OYQQVwye8OKJnx-wBb0zvIr6Nkz68Q6_b1CpcPL3n6P7q693yW7b-vrpeLtaZKhihmQYGnFWUFVtdSclYVepcsqZVumxyluYB29R3zRsN0BLGoa64rhsgoNt2q-k5-vLIO07bAbSCudVejN4M0h-Ek0b8HbHmh-jcXuSkIbSoy8Tw_onBu58ThCgGE1QaqLTgpiAKnjdVTquKJOjln8VeqjyvJgHYI0ClqQQP7QskJ2KWgdiN4lkG4igDMcsgJX7-J1GZKOdtpk-b_n_pvwHwfsKf
CitedBy_id crossref_primary_10_2147_OPTH_S483055
crossref_primary_10_1159_000542199
crossref_primary_10_31083_j_fbl2912410
Cites_doi 10.1017/S0952523899163028
10.1167/iovs.13-12634
10.1016/j.ophtha.2007.08.023
10.1167/iovs.04-0199
10.1167/tvst.7.1.11
10.1007/s10633-020-09760-5
10.1016/j.ophtha.2008.10.026
10.1016/j.ophtha.2015.06.015
10.1016/j.ophtha.2008.12.032
10.1159/000267663
10.4103/tjo.tjo_106_17
10.1016/j.ophtha.2003.04.007
10.1001/archopht.120.10.1268
10.1016/j.visres.2010.08.036
10.1016/j.ophtha.2004.09.002
10.1155/2021/8025337
10.1007/s10633-017-9575-0
10.1016/j.exer.2011.01.014
10.1007/BF02133775
10.1007/BF00146546
10.1007/s40123-020-00302-5
10.5005/jp-journals-10078-1365
10.1007/s10633-022-09869-9
10.1371/journal.pone.0214875
10.1023/A:1020553020264
10.1097/IJG.0b013e31819afb5c
10.3928/15428877-20121001-01
10.1016/j.ophtha.2010.08.049
10.1007/s10633-007-9053-1
10.1038/s41433-021-01603-0
10.1097/IJG.0b013e318193c2e1
10.1016/j.exer.2015.05.008
10.1186/s12889-019-6935-6
10.1167/iovs.11-7896
10.1159/000310622
10.1016/j.ophtha.2004.07.018
10.1097/IJG.0000000000000203
10.1371/journal.pone.0220992
10.1097/IJG.0000000000001103
10.1007/s10633-022-09900-z
10.1167/iovs.12-10345
10.1167/iovs.12-11026
10.3238/arztebl.2009.0597
10.1001/archopht.120.6.701
10.1167/iovs.03-1411
10.3390/cells10061398
ContentType Journal Article
Copyright Copyright © 2023; The Author(s).
Copyright © 2023; The Author(s). 2023
Copyright_xml – notice: Copyright © 2023; The Author(s).
– notice: Copyright © 2023; The Author(s). 2023
DBID AAYXX
CITATION
NPM
7X8
5PM
DOI 10.5005/jp-journals-10078-1423
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 0975-1947
EndPage 190
ExternalDocumentID PMC10803274
38269268
10_5005_jp_journals_10078_1423
Genre Journal Article
GroupedDBID ---
8R4
8R5
AAYXX
ACZLU
ADBBV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
DIK
EMOBN
HYE
KQ8
M48
OK1
PGMZT
PW6
Q2X
RPM
SV3
ADRAZ
NPM
7X8
5PM
ID FETCH-LOGICAL-c2603-de6e965362bd5aa6654d1a68fcd4816097eb826798deef069e759d78e0edffbd3
IEDL.DBID M48
ISSN 0974-0333
IngestDate Thu Aug 21 18:36:16 EDT 2025
Fri Jul 11 06:44:11 EDT 2025
Thu Jan 02 22:27:28 EST 2025
Tue Jul 01 00:45:44 EDT 2025
Thu Apr 24 23:04:30 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 4
Keywords Retinal ganglion cells
Glaucoma suspects
Ganglion cell layer + inner plexiform layer
Retinal nerve fiber layer thickness
Pattern electroretinogram
Intraocular pressure treatment
Language English
License Copyright © 2023; The Author(s).
The Author(s). 2023 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2603-de6e965362bd5aa6654d1a68fcd4816097eb826798deef069e759d78e0edffbd3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.5005/jp-journals-10078-1423
PMID 38269268
PQID 2918513550
PQPubID 23479
PageCount 13
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10803274
proquest_miscellaneous_2918513550
pubmed_primary_38269268
crossref_primary_10_5005_jp_journals_10078_1423
crossref_citationtrail_10_5005_jp_journals_10078_1423
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023 Oct-Dec
PublicationDateYYYYMMDD 2023-10-01
PublicationDate_xml – month: 10
  year: 2023
  text: 2023 Oct-Dec
PublicationDecade 2020
PublicationPlace India
PublicationPlace_xml – name: India
PublicationTitle Journal of current glaucoma practice
PublicationTitleAlternate J Curr Glaucoma Pract
PublicationYear 2023
Publisher Jaypee Brothers Medical Publishers
Publisher_xml – name: Jaypee Brothers Medical Publishers
References ref=27
ref=26
ref=25
ref=24
ref=23
ref=22
ref=21
ref=20
ref=1
ref=29
ref=28
ref=7
ref=6
ref=9
ref=8
ref=3
ref=2
ref=5
ref=4
ref=30
ref=38
ref=37
ref=36
ref=35
ref=34
ref=33
ref=32
ref=31
ref=39
ref=41
ref=40
ref=49
ref=48
ref=47
ref=46
ref=45
ref=44
ref=43
ref=42
ref=52
ref=51
ref=50
ref=16
ref=15
ref=14
ref=13
ref=12
ref=11
ref=55
ref=10
ref=54
ref=53
ref=19
ref=18
ref=17
References_xml – ident: ref=18
  doi: 10.1017/S0952523899163028
– ident: ref=7
– ident: ref=44
  doi: 10.1167/iovs.13-12634
– ident: ref=3
– ident: ref=39
  doi: 10.1016/j.ophtha.2007.08.023
– ident: ref=36
  doi: 10.1167/iovs.04-0199
– ident: ref=49
  doi: 10.1167/tvst.7.1.11
– ident: ref=54
  doi: 10.1007/s10633-020-09760-5
– ident: ref=38
  doi: 10.1016/j.ophtha.2008.10.026
– ident: ref=12
  doi: 10.1016/j.ophtha.2015.06.015
– ident: ref=43
  doi: 10.1016/j.ophtha.2008.12.032
– ident: ref=24
  doi: 10.1159/000267663
– ident: ref=48
  doi: 10.4103/tjo.tjo_106_17
– ident: ref=19
– ident: ref=14
  doi: 10.1016/j.ophtha.2003.04.007
– ident: ref=27
  doi: 10.1001/archopht.120.10.1268
– ident: ref=30
  doi: 10.1016/j.visres.2010.08.036
– ident: ref=55
– ident: ref=6
  doi: 10.1016/j.ophtha.2004.09.002
– ident: ref=8
  doi: 10.1155/2021/8025337
– ident: ref=28
  doi: 10.1007/s10633-017-9575-0
– ident: ref=42
  doi: 10.1016/j.exer.2011.01.014
– ident: ref=20
  doi: 10.1007/BF02133775
– ident: ref=22
  doi: 10.1007/BF00146546
– ident: ref=51
  doi: 10.1007/s40123-020-00302-5
– ident: ref=26
– ident: ref=35
  doi: 10.5005/jp-journals-10078-1365
– ident: ref=23
– ident: ref=33
  doi: 10.1007/s10633-022-09869-9
– ident: ref=32
  doi: 10.1371/journal.pone.0214875
– ident: ref=17
  doi: 10.1023/A:1020553020264
– ident: ref=37
  doi: 10.1097/IJG.0b013e31819afb5c
– ident: ref=5
– ident: ref=50
  doi: 10.3928/15428877-20121001-01
– ident: ref=15
  doi: 10.1016/j.ophtha.2010.08.049
– ident: ref=40
  doi: 10.1007/s10633-007-9053-1
– ident: ref=31
  doi: 10.1038/s41433-021-01603-0
– ident: ref=53
  doi: 10.1097/IJG.0b013e318193c2e1
– ident: ref=1
  doi: 10.1016/j.exer.2015.05.008
– ident: ref=11
  doi: 10.1186/s12889-019-6935-6
– ident: ref=46
  doi: 10.1167/iovs.11-7896
– ident: ref=2
– ident: ref=25
  doi: 10.1159/000310622
– ident: ref=52
  doi: 10.1016/j.ophtha.2004.07.018
– ident: ref=45
  doi: 10.1097/IJG.0000000000000203
– ident: ref=41
  doi: 10.1371/journal.pone.0220992
– ident: ref=10
  doi: 10.1097/IJG.0000000000001103
– ident: ref=34
  doi: 10.1007/s10633-022-09900-z
– ident: ref=9
  doi: 10.1167/iovs.12-10345
– ident: ref=13
  doi: 10.1167/iovs.12-11026
– ident: ref=21
– ident: ref=29
  doi: 10.3238/arztebl.2009.0597
– ident: ref=4
  doi: 10.1001/archopht.120.6.701
– ident: ref=16
  doi: 10.1167/iovs.03-1411
– ident: ref=47
  doi: 10.3390/cells10061398
SSID ssj0000400099
Score 2.2408369
Snippet To evaluate the ability of pattern electroretinogram (PERG) to detect improvement of retinal ganglion cell (RGC) function in glaucoma suspects (GS) after...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 178
SubjectTerms Original Research
Title Retinal Ganglion Cell Functional Recovery after Intraocular Pressure Lowering Treatment Using Prostaglandin Analogs in Glaucoma Suspects: A Prospective Pilot Study
URI https://www.ncbi.nlm.nih.gov/pubmed/38269268
https://www.proquest.com/docview/2918513550
https://pubmed.ncbi.nlm.nih.gov/PMC10803274
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Nb9QwELVKkRCXClqgC6UyEle368Rx7F6qqmLbIhZV0JV6ixzbga2iZNkPqft7-kc74yQrtlTALVLsRMlMMu_ZM_MI-WiklQhTGfz9cyasLVguNGfA27xRnFsX-swOv8rzkfh8nVxvkE4utX2Bs0epHepJjablwe2v5TF88IBfDxJwosObCevmMdz0B1oEIOEJeQrRSSIhG7aQP_ydRUBFoQVfKlg_juOmcPgvl1qPWX8A0Yf5lL8FqMELstUiS3rSuMJLsuGrbfJs2O6d75C7b1jdDCPODJbu1hU99WVJBxDYmvVAilQUPHtJg3A4vcDb1CFPlTZVhFNPv6CqGoQ7etVlqNOQdQAjagCaQRFkXFHsdVL_mFE4PCvNAtza0O-LUNY5O6InYXRb40kvx2U9p5jQuHxFRoNPV6fnrJVoYBaIUMycl17LBKJg7hJjUMrYcSNVYZ1QXMIr9jkQmFQr533Rl9qniXap8n3viiJ38WuyWdWV3yUUDFFILXRuFRep43lkVeSLiLsYKJpIeiTpjJDZtn85ymiUGfAYNF52M8k644VWzCpD4_XI4WrepOng8c8ZHzobZ_Cx4Q6KqXy9mGWRBnjDAaL1e-RNY_PVNWN4Th1J1SNqzRtWA7CR9_qZavwzNPTGPM84SsXb_7jxO_IcFe-bfMI9sjmfLvx7wEXzfD84-n5YsLoHkw4Sxg
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Retinal+Ganglion+Cell+Functional+Recovery+after+Intraocular+Pressure+Lowering+Treatment+Using+Prostaglandin+Analogs+in+Glaucoma+Suspects%3A+A+Prospective+Pilot+Study&rft.jtitle=Journal+of+current+glaucoma+practice&rft.au=Tirsi%2C+Andrew&rft.au=Gliagias%2C+Vasiliki&rft.au=Sheha%2C+Hosam&rft.au=Patel%2C+Bhakti&rft.date=2023-10-01&rft.issn=0974-0333&rft.volume=17&rft.issue=4&rft.spage=178&rft_id=info:doi/10.5005%2Fjp-journals-10078-1423&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0974-0333&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0974-0333&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0974-0333&client=summon